Evaluating the Efficacy of Oral Semaglutide in Chinese Patients with Type 2 Diabetes by Baseline Characteristics-Post Hoc Analysis of PIONEER 11 and 12

被引：0
|
作者：
Ji, Linong
Yuan, Guoyue
Liu, Jun
Zhang, Bingjie
Liu, Wenyan
Shen, Zewei
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-752-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
752-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis
    Patel, Hiren
    Munir, Kashif
    Sutherland, Sindee
    Karanikas, Chrisanthi A.
    Konig, Manige
    DIABETES THERAPY, 2019, 10 (06) : 2321 - 2330
  • [42] Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis
    Hiren Patel
    Kashif Munir
    Sindee Sutherland
    Chrisanthi A. Karanikas
    Manige Konig
    Diabetes Therapy, 2019, 10 : 2321 - 2330
  • [43] Efficacy and safety of once-weekly semaglutide in elderly subjects with type 2 diabetes: post hoc analysis of SUSTAIN 1-5 trials
    Warren, M.
    Chaykin, L.
    Trachtenbarg, D.
    Nayak, G.
    Wijayasinghe, N.
    Cariou, B.
    DIABETOLOGIA, 2017, 60 : S378 - S379
  • [44] Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naive Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1
    Li, Yi Ming
    Zhang, Li Hui
    Li, Xue Jun
    Zhang, Bin
    Hou, Jia Ning
    Tong, Nan Wei
    DIABETES THERAPY, 2020, 11 (05) : 1077 - 1090
  • [45] Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placebo
    Lavernia, Frank
    Blonde, Lawrence
    POSTGRADUATE MEDICINE, 2020, 132 : 15 - 25
  • [46] Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
    Kuang, Jian
    Zhu, Jiankun
    Liu, Siying
    Li, Quanmin
    DIABETES THERAPY, 2020, 11 (10) : 2329 - 2339
  • [47] The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study
    Kitsunai, Hiroya
    Shinozaki, Yuka
    Furusawa, Sho
    Kitao, Naoyuki
    Ito, Miki
    Kurihara, Hiroyoshi
    Oba-Yamamoto, Chiho
    Takeuchi, Jun
    Nakamura, Akinobu
    Takiyama, Yumi
    Nomoto, Hiroshi
    PHARMACEUTICALS, 2025, 18 (01)
  • [48] Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
    Jian Kuang
    Jiankun Zhu
    Siying Liu
    Quanmin Li
    Diabetes Therapy, 2020, 11 : 2329 - 2339
  • [49] Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
    Mosenzon, Ofri
    Blicher, Thalia Marie
    Rosenlund, Signe
    Eriksson, Jan W.
    Heller, Simon
    Hels, Ole Holm
    Pratley, Richard
    Sathyapalan, Thozhukat
    Desouza, Cyrus
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (07): : 515 - 527
  • [50] Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post-hoc analysis
    Araki, Eiichi
    Harashima, Shinichi
    Nishida, Tomoyuki
    Nakamura, Jiro
    JOURNAL OF DIABETES INVESTIGATION, 2022, : 1971 - 1980
12345